Sponsor or institution

Clinical trials and research at The Lymphoma Academic Research Organisation

• 8Clinical trials
• 5Countries

Newest trials

All recruiting trials (8)

• Testing new drugs and combinations for relapsed or refractory peripheral T‑cell lymphoma

  This project will try different new drugs and drug combinations to see if they help people with relapsed or refractory peripheral T‑cell lymphoma.

  Recruiting at 19 sites Phase 1/2 The Lymphoma Academic Research Organisation · Angers and 19 other locations · NCT07018752

• Real-world outcomes with glofitamab for large B-cell lymphoma

  This project looks at how well glofitamab works and how safe it is for adults in France with relapsed or refractory large B‑cell lymphoma who were treated through the expanded access program.

  Recruiting at 30 sites The Lymphoma Academic Research Organisation · Argenteuil and 29 other locations · NCT06994169

• Epcoritamab with lenalidomide and rituximab for relapsed or refractory primary diffuse large B‑cell lymphoma of the CNS

  This phase 2 test tries to see if adding epcoritamab to lenalidomide and rituximab helps adults with relapsed or refractory primary CNS diffuse large B‑cell lymphoma.

  Recruiting at 9 sites Phase 2 The Lymphoma Academic Research Organisation · Bordeaux and 12 other locations · NCT06931652

• Evaluating Glofitamab with Venetoclax and Zanubrutinib for high-risk Mantle-cell Lymphoma

  This study is testing a new combination of treatments for people with high-risk Mantle-cell Lymphoma to see if it helps them better than current options.

  Recruiting at 16 sites Phase 2 The Lymphoma Academic Research Organisation · Bruges and 15 other locations · NCT06558604

• Golcadomide treatment after CAR T-cell therapy for aggressive large B-cell lymphoma

  This study is testing if golcadomide can help people with aggressive large B-cell lymphoma stay in remission after they receive CAR T-cell therapy.

  Recruiting at 13 sites Phase 2 The Lymphoma Academic Research Organisation · Créteil and 12 other locations · NCT06271057

• Comparing Mosunetuzumab-Lenalidomide to other treatments for relapsed or refractory Marginal Zone Lymphoma

  This study is testing if a new combination of Mosunetuzumab and Lenalidomide can help people with relapsed or refractory Marginal Zone Lymphoma feel better compared to other standard treatments they might have already tried.

  Recruiting at 26 sites Phase 3 The Lymphoma Academic Research Organisation · Anderlecht and 47 other locations · NCT06006117

• Registry of patients eligible for CAR-T cell treatment in France

  This study is gathering information about patients with blood cancers who are considered for CAR-T cell treatment in France to see how well the therapy works for them.

  Recruiting at 36 sites The Lymphoma Academic Research Organisation · Amiens and 35 other locations · NCT04328298

• Registry for women with breast implant-associated lymphoma

  This study is collecting information from women with a rare type of lymphoma linked to breast implants to help doctors understand and manage the condition better.

  Recruiting at 28 sites The Lymphoma Academic Research Organisation · Bruges and 30 other locations · NCT04220970

Quick answers

How many clinical trials run by The Lymphoma Academic Research Organisation are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 5 countries. The most sites are in France (8 trials), Belgium (3 trials), Germany (1 trial), Italy (1 trial), Portugal (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →